Details for Patent: RE46276
✉ Email this page to a colleague
Which drugs does patent RE46276 protect, and when does it expire?
Patent RE46276 protects BRILINTA and is included in one NDA.
Protection for BRILINTA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has eighty-five patent family members in thirty-four countries.
Summary for Patent: RE46276
| Title: | Triazolo(4,5-D)pyrimidine compounds |
| Abstract: | Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. The compounds of the invention have the formula (I) as follows: ##STR00001## wherein R, X and R.sup.1 through R.sup.3 are as defined in the specification. |
| Inventor(s): | Hardem; David (Sutton Bonington, GB), Ingall; Anthony (Minehead, GB), Springthorpe; Brian (Stanford on Soar, GB), Willis; Paul (Geneva, CH), Guile; Simon (Hathern, GB) |
| Assignee: | AstraZeneca UK Limited (London, GB) |
| Application Number: | 14/976,977 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent RE46276 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Process; Dosage form; |
Drugs Protected by US Patent RE46276
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | BRILINTA | ticagrelor | TABLET;ORAL | 022433-002 | Sep 3, 2015 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Astrazeneca | BRILINTA | ticagrelor | TABLET;ORAL | 022433-001 | Jul 20, 2011 | AB | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: RE46276
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| Sweden | 9804211 | Dec 4, 1998 |
| Sweden | 9901271 | Apr 9, 1999 |
| PCT Information | |||
| PCT Filed | December 02, 1999 | PCT Application Number: | PCT/SE99/02256 |
| PCT Publication Date: | June 15, 2000 | PCT Publication Number: | WO00/34283 |
International Family Members for US Patent RE46276
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 023920 | ⤷ Try a Trial | |||
| Argentina | 058967 | ⤷ Try a Trial | |||
| Argentina | 072756 | ⤷ Try a Trial | |||
| Austria | 261970 | ⤷ Try a Trial | |||
| Austria | 418547 | ⤷ Try a Trial | |||
| Austria | 513816 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
